Overview

PK/PD of Extended-infusion Meropenem, Piperacillin-tazobactam and Cefepime in the Early Phase of Septic Shock

Status:
Unknown status
Trial end date:
2018-09-01
Target enrollment:
Participant gender:
Summary
This study evaluates PK/PD of an extended-infusion protocol of meropenem, piperacillin-tazobactam and cefepime, in the early phase of septic shock.
Phase:
Phase 3
Details
Lead Sponsor:
Centre Hospitalier Universitaire de Besancon
Treatments:
Cefepime
Cephalosporins
Meropenem
Penicillanic Acid
Piperacillin
Piperacillin, Tazobactam Drug Combination
Tazobactam
Thienamycins